Bill > HR0158

This resolution directs the Illinois Auditor General to conduct a comprehensive investigation of the 340B Drug Pricing Program, a federal initiative originally designed to help safety-net healthcare providers obtain discounted medications for low-income and uninsured patients. The investigation will assess multiple aspects of the program, including the total 340B profits generated by covered entities, the amount spent on program management, payments to pharmacy benefit managers (PBMs) and contract pharmacies, drug pricing markups, and the extent to which discounts are actually passed on to vulnerable patients. The resolution highlights concerns that the program has strayed from its original intent, noting that nationally the program reached $66.3 billion in 2023, while Illinois hospitals provide only 2.14% of charity care. The Auditor General is specifically asked to examine the program's impact on state health programs like Medicaid and the State Employees Group Insurance Program, and to develop recommendations for improving the program's transparency and effectiveness in serving vulnerable populations. The resolution will be delivered to key state officials to emphasize the commitment to understanding and potentially reforming the 340B Program.

Government Affairs, Health and Social Services

https://www.ilga.gov/legislation/BillStatus.asp?DocNum=158&GAID=18&DocTypeID=HR&SessionID=114&GA=104